Cristina Prat‐Vidal

Design and validation of a GMP-compliant manufacturing platform of extracellular vesicles from mesenchymal stromal cells

There is growing interest in mesenchymal stromal cell-derived extracellular vesicles (MSC-EVs) as key components in the development of next-generation regenerative cell-free therapies; however, their clinical translation remains limited by a lack of validated clinical-grade manuf...